Small Cell Lung Cancer Extensive Stage Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC170 enrolled31 locationsNCT07227597
Recruiting
Phase 2
Liposomal Irinotecan and Apatinib in ES-SCLC
Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, School of Medicine, Zhejiang University30 enrolled1 locationNCT06749691